Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Elite, a specialty pharmaceutical company developing niche generic products, has shipped its first lot of finished product ...

Biologics contract manufacturing, or BCM, refers to the collaboration between a pharmaceutical company ... Upstream processing – cell line development, cell culture, and bioreactor operations ...

Comparatively, the continuous manufacturing process involves a single line of different unit operations in which the flow of materials is uninterrupted. For many years, the pharmaceutical industry ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

UCB Pharma has announced that Exemed Pharmaceuticals, a fast-growing Indian manufacturing company ... The agreement is in line with UCB’s current strategy to focus on bringing new innovative ...

ProRx Pharma, the wellness and longevity 503B outsourcing facility, has announced the expansion of its operations to help meet the demand for critical medications—now and into the future with a full ...

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Eli Lilly (LLY) on Wednesday outlined a plan to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the US. The pharmaceutical giant said that three of the planned ...

Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche ...